LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000051.4:c.8921C>T
ATM
· NP_000042.3:p.(Pro2974Leu)
· NM_000051.4
GRCh37: chr11:108235879 C>T
·
GRCh38: chr11:108365152 C>T
Gene:
ATM
Transcript:
NM_000051.4
Final call
Likely Benign
PS3 supporting
PS4 strong
BS1 strong
BS3 supporting
BP4 supporting
Variant details
Gene
ATM
Transcript
NM_000051.4
Protein
NP_000042.3:p.(Pro2974Leu)
gnomAD AF
9.788627597238864e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Pathogenic evidence: PS3 supporting reports impaired ATM phosphorylation and DNA-repair rescue.
2
Pathogenic evidence: PS4 strong reports 13/7,204 cases versus 0/9,593 controls with p=1.7 × 10^-5.
3
Likely Benign: BS1 strong is met because gnomAD v4.1 grpmax filtering AF is 0.193551%, exceeding 0.05%.
4
Likely Benign: BS3 supporting reflects a direct prime-editing Functional result with High confidence.
5
Likely Benign: BP4 supporting is met by REVEL 0.148, below the VCEP cutoff of 0.249.
Final determination:
Under the ATM VCEP Version 1.6 framework, BS1 at Strong satisfies Rule20 for Likely Benign, with BS3 and BP4 also satisfying Rule19, and no pathogenic rule is met.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.8921C>T is a missense SNV (p.Pro2974Leu) in exon 62, not a PVS1 null-variant class. |
vcep_suppl_tables1_pmid_40580951
vcep_atm_pvs1_1_6
|
| PS1 | Not met | Not met: ATM PS1 requires a previously established pathogenic variant with the same amino-acid change, but ATM_PS1_1.6 has no c.8921C>T, p.Pro2974Leu, or p.P2974L entry. |
cspec
vcep_atm_ps1_1_6
|
| PS2 | N/A | Not applicable: the ATM VCEP marks PS2 not applicable, and the variant-specific report documents paternal inheritance rather than a de novo event. |
cspec
PMID:12511424
|
| PS3 | Met | Met, Supporting: variant-specific studies show reduced ATM phosphorylation and impaired DNA-repair rescue, while Sun et al. reports Functional in direct prime editing. |
cspec
vcep_suppl_tables1_pmid_40580951
PMID:40580951
PMID:12511424
PMID:31160347
vcep_clingen_hbop_atm_supplementary_tables_1_and_2_v1
|
| PS4 | Met | Met, Strong: 13/7,204 cases versus 0/9,593 controls, p=1.7 x 10^-5 <= .05, corrected OR=36.018, and lower 95% CI=2.141 >=1.5. |
cspec
PMID:31160347
|
| PM1 | N/A | Not applicable: the ATM VCEP explicitly marks PM1 as Not Applicable, and no authoritative ATM domain-table entry is present. |
cspec
|
| PM2 | Not met | Not met: the highest gnomAD v4.1 subpopulation AF is 0.22949% (103/44882), exceeding the VCEP PM2 threshold of <=0.001%. |
cspec
gnomad_v4
|
| PM3 | Not met | Not met: the exact variant was heterozygous in a leukemia patient, with paternal inheritance and no reported A-T diagnosis or pathogenic ATM variant in trans. |
cspec
vcep_atm_pm3_bp2_1_6
PMID:12511424
|
| PM4 | N/A | Not applicable: the variant is a missense substitution, whereas the ATM VCEP limits PM4 to stop-loss variants. |
vcep_suppl_tables1_pmid_40580951
cspec
|
| PM5 | N/A | Not applicable: PM5 is limited to NMD-prone truncating variants with PVS1 Very Strong and premature termination codons upstream of p.Leu3048, whereas this is missense. |
cspec
|
| PM6 | N/A | Not applicable: the ATM VCEP marks PM6 not applicable, and the reported variant was inherited from a heterozygous father. |
cspec
PMID:12511424
|
| PP1 | N/A | Not applicable: the VCEP limits PP1 to autosomal-recessive segregation in affected relatives, while this report shows paternal inheritance without qualifying affected-relative segregation. |
cspec
PMID:12511424
|
| PP2 | N/A | Not applicable: the ATM VCEP explicitly marks PP2 as Not Applicable, so no gene-level missense-mechanism evidence can be assigned under this framework. |
cspec
|
| PP3 | Not met | Not met: REVEL 0.148 is below the >0.7333 PP3 threshold and SpliceAI maximum delta 0.006 is below the >=0.2 threshold. |
cspec
vcep_suppl_tables1_pmid_40580951
PMID:40580951
revel
spliceai
|
| PP4 | N/A | Not applicable: the ATM VCEP explicitly marks PP4 as Not Applicable. |
cspec
|
| PP5 | N/A | Not applicable: the ATM VCEP explicitly marks PP5 as Not Applicable. |
cspec
|
| BA1 | Not met | Not met: gnomAD v4.1 grpmax Filtering AF is 0.193551%, below the VCEP BA1 threshold of >0.5%. |
cspec
gnomad_v4
|
| BS1 | Met | Met, Strong: gnomAD v4.1 grpmax Filtering AF is 0.193551%, exceeding the VCEP BS1 threshold of >0.05%. |
cspec
gnomad_v4
|
| BS2 | N/A | Not applicable: the ATM VCEP says not to use BS2 because ATM has incomplete penetrance. |
cspec
|
| BS3 | Met | Met, Supporting: Table S1 directly measures the variant as Functional with High confidence, but published assays report abnormal ATM activity and require human review. |
cspec
vcep_suppl_tables1_pmid_40580951
PMID:40580951
PMID:12511424
PMID:31160347
vcep_clingen_hbop_atm_supplementary_tables_1_and_2_v1
|
| BS4 | N/A | Not applicable: the ATM VCEP marks BS4 not applicable, despite the heterozygous father being free of malignant disease at publication. |
cspec
PMID:12511424
|
| BP1 | N/A | Not applicable: the ATM VCEP explicitly marks BP1 as Not Applicable, so no generic benign missense-location evidence can be assigned. |
cspec
|
| BP2 | Not met | Not met: no cis or trans pathogenic-variant observation in an unaffected adult was reported for this heterozygous variant. |
cspec
vcep_atm_pm3_bp2_1_6
PMID:12511424
|
| BP3 | N/A | Not applicable: the ATM VCEP v1.6 CSPEC explicitly marks BP3 as Not Applicable for this assessment framework. |
cspec
vcep_suppl_tables1_pmid_40580951
|
| BP4 | Met | Met: missense REVEL 0.148 is at or below the VCEP BP4 cutoff of <=0.249. |
cspec
vcep_suppl_tables1_pmid_40580951
PMID:40580951
revel
spliceai
|
| BP5 | N/A | Not applicable: the ATM VCEP explicitly marks BP5 as Not Applicable. |
cspec
|
| BP6 | N/A | Not applicable: the ATM VCEP explicitly marks BP6 as Not Applicable. |
cspec
|
| BP7 | N/A | Not applicable: p.Pro2974Leu is a missense substitution, whereas BP7 is limited to synonymous or deep intronic variants. |
cspec
pvs1_variant_assessment
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.